Crossmark

A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes

Crossref DOI link: https://doi.org/10.1186/s13054-021-03757-5

Published Online: 2021-09-17

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guirgis, Faheem W. http://orcid.org/0000-0002-4445-3939
Black, Lauren Page

Henson, Morgan

Labilloy, Guillaume

Smotherman, Carmen

Hopson, Charlotte

Tfirn, Ian

DeVos, Elizabeth L.

Leeuwenburgh, Christiaan

Moldawer, Lyle

Datta, Susmita

Brusko, Todd M.

Hester, Alexis

Bertrand, Andrew

Grijalva, Victor

Arango-Esterhay, Alexander

Moore, Frederick A.

Reddy, Srinivasa T.
Funding

Funding for this research was provided by:

National Institute of General Medical Sciences (K23GM115690, R01GM133815, P50GM111152)

National Institute of Allergy and Infectious Diseases (P01AI042288)

National Center for Advancing Translational Sciences (KL2TR001429)
License Information

Text and Data Mining valid from 2021-09-17

Version of Record valid from 2021-09-17
More Information

Article History

Received: 9 February 2021

Accepted: 1 September 2021

First Online: 17 September 2021

Declarations

:

: This study was approved by the institutional review boards of the University of Florida College of Medicine, and all participants provided written consent before study participation.

: All authors have provided consent for publication of the manuscript.

: The authors have no competing interests to report. All authors have read Biomed Central’s section on competing interests and have no competing interests to disclose.

Document is current

Any future updates will be listed below